Physis Capital India Growth Opportunity

Our view on the fund, the AMC, the strategy, the performance & the investment team.

IME's Review of Physis Capital India Growth Opportunity

Fund RatingStrategy RatingPerformance Rating
Upgrade
Upgrade
Upgrade
Recommendation
Upgrade
Strategy Definition
Upgrade
5yr Performance
Upgrade
LT Performance
Upgrade
Strategy Desc
Upgrade

View on the Fund

Physis Capital India Growth Opportunity Fund can be considered for investment, given the AMC’s strong credibility and extensive network built through its previous ventures. However, as this is their first AIF, we would prefer to wait and observe how they establish their track record, especially given the inherent lack of visibility and information in the unlisted AIF space.

Strategy

Fund's Strategy View

Physis Capital India Growth Opportunity Fund focuses on high-growth, technology-driven startups from Pre-Series A to Series B, leveraging its strong network for sourcing, due diligence, and support. The fund targets 15-18 multi-sector startups across Fintech, SaaS, Enterprise-tech, Consumer-tech, Mobility, Ed-tech, Deep-tech, Health-tech, and Logistics.

Fund Performance

Performance is highly based on power law, where a handful of investment make up for majority of returns. Network and ability to source deals is a key aspect of unlisted returns.

Trailing Performance

1yr3yr5yrSince Inception
Physis Capital India Growth Opportunity

Performance as of: 31-Jan-26

Investment team

Ankur Mittal | 3-star rated FM

Co-Founder | 21 yrs Experience | 4 yrs at current firm

Past Experience: IPV, TTS, Credit Suisse

Ankur Mittal is a Partner at Physis Capital. Prior to this, he co-founded Inflection Point Ventures (IPV), an early-stage angel investing platform. Earlier in his career, Ankur served as Head of Asia and Middle East for Training The Street (TTS), was an Associate in Investment Banking M&A at Credit Suisse, and held the position of Vice President at Citigroup Pension Investments. He has invested in over 75 startups.

Mitesh Shah | 3-star rated FM

Co-Founder | 24 yrs Experience | 4 yrs at current firm

Past Experience: IPV, Ola, BookMyShow

Mitesh Shah is a Partner at Physis Capital. He is also a Co-Founder of Inflection Point Ventures (IPV), an early-stage angel investing platform. Before his current roles, Mitesh served as the Chief Financial Officer (CFO) at Ola and BookMyShow, and as Vice President of Finance & Corporate Affairs at Mandhana Industries Ltd. He has been an active angel investor, with over 120 investments, and was recognized as the 32nd Angel on Fortune India's Top 100 list.

Vinay Bansal | 3-star rated FM

Co-Founder | 23 yrs Experience | 4 yrs at current firm

Past Experience: IPV, TPG Global, Wildcraft India, General Electric, Hindustan Unilever

Vinay Bansal is the Co-Founder of Physis Capital. Prior to this, he served as the Founder & CEO of Inflection Point Ventures, an early-stage angel investing platform. Before his entrepreneurial ventures, Vinay was a Senior Advisor at TPG Global and held the positions of Chief Financial Officer (CFO) and Chief Investment Officer (CIO) at Wildcraft India. He also served as CFO for Supply Chain (South Asia) at General Electric (GE) and held leadership roles at Hindustan Unilever.

IME's Review of Physis Capital

AMC RatingPedigree RatingTeam RatingPhilosophy Rating
Upgrade
Upgrade
Upgrade
Upgrade
AMC Pedigree
Upgrade
Team Pedigree
Upgrade
FM Churn Risk
Upgrade
AMC Maturity
Upgrade
Philosphy Name
Upgrade
Inv Philosophy
Upgrade
Investment Team
Upgrade

View on AMC

Physis Capital brings the necessary tools and experience to operate a VC AIF, backed by an extensive network and an experienced team. While they are well-positioned, their performance credibility remains uncertain due to the inherent opacity and delayed visibility in the unlisted space.

AMC's Pedigree

Physis Capital is a VC fund launched by Inflection Point Ventures (IPV), an established angel investing firm that supports new-age entrepreneurs with both financial and experiential capital. Leveraging its extensive investor network and deep expertise in early-stage investments, transitioning into a VC AIF is a natural progression, aligning with its existing pedigree in the space.

AMC Team

The founding team of Physis Capital brings extensive pedigree as angel investors and co-founders of IPV, and are now leveraging their expertise to transition into the AIF space.

Investment Philosophy

Their investment philosophy is rooted in their proven ability to acquire and scale startups, leveraging a vast network, industry-expert due diligence, and active mentorship to drive value creation.

AMC Background

Physis Capital is an India-focused growth-stage investment platform positioned as an operator-led alternative asset manager, with its flagship offering being the India Growth Opportunity Fund. The platform has been purpose-built to invest in technology-enabled, growth-stage Indian startups, typically spanning Pre-Series A to Series B, where business models are validated but institutional capital and operational depth can materially accelerate scale. Physis draws heavily on the institutional and experiential foundation built through its association with Inflection Point Ventures (IPV), one of India’s largest angel investing platforms, which has evaluated over 17,000 startups and invested in more than 215 companies over the past five years.

The AMC is distinguished by a deeply operational DNA. The general partners and senior leadership collectively bring decades of hands-on experience in building, scaling, turning around, and exiting businesses across consumer tech, fintech, enterprise technology, logistics, health-tech, and climate-tech. This includes prior experience of taking companies from early scale to IPO, executing M&A transactions, and delivering full and partial exits at meaningful multiples.

Investment Philosophy

Physis Capital’s investment philosophy is centred on identifying and nurturing high-potential Indian startups that are solving real, large-scale problems with technology as an enabler. The core objective is to invest at a stage where execution risk is moderated, but valuation inefficiencies and growth optionality remain substantial. The fund targets businesses that have already demonstrated early product–market fit and operating traction, and are poised to emerge as category leaders with the right capital, governance, and strategic support.

The philosophy combines disciplined selection with active ownership. Physis does not pursue broad-based portfolio diversification; instead, it constructs a relatively concentrated portfolio of 15–18 companies, enabling meaningful involvement in each investment. Capital is deployed only where founders demonstrate strong integrity, ambition, and execution capability, and where businesses can scale sustainably at fair valuations rather than speculative pricing.

Sourcing Advantage

Deal sourcing is a core competitive advantage for Physis. The platform leverages a wide ecosystem comprising over 200 venture capital and private equity firms, 30+ incubators and accelerators, investment banks, institutional partners, and a large founder and angel investor network. This ecosystem-driven sourcing allows Physis to selectively cherry-pick high-quality opportunities from a vast funnel, with an acceptance rate of roughly 1% from over 17,000 evaluated startups.

Due diligence is partner-led and highly granular, combining financial, legal, and business diligence with deep sectoral inputs from subject-matter experts and industry practitioners. Each investment is assessed across a proprietary framework covering market size, competitive moats, unit economics, scalability, governance standards, and founder alignment. The process is explicitly designed to reduce behavioural and execution risk rather than chase headline growth.

Active Ownership

A defining pillar of Physis Capital’s philosophy is hands-on post-investment involvement. Beyond capital, portfolio companies receive sustained technical, operational, and strategic mentorship. This includes support in senior management hiring, working capital optimisation, financial controls, governance structuring, KPI and operating rhythm design, and access to debt, VC, and PE networks for follow-on funding. The platform actively identifies super-performing portfolio companies and selectively doubles down through follow-on investments to enhance overall fund IRR.

Exit planning is integrated early into the investment lifecycle. Physis focuses on enabling both full and opportunistic exits through strategic sales, secondary transactions, or later-stage institutional rounds, rather than relying solely on long-duration holding. This exit-aware approach is intended to improve capital recycling, reduce tail risk, and deliver more predictable outcome distributions for investors.

Experience the benefits of working with a 'research-first' investments firm

Free 15-Day Trial of IME RMS App

Get complimentary access to the revolutionary IME RMS App (direct access to IME's central team insights across 1000's of MFs, PMSs, AIFs & Global funds - a first in the industry).

Additionally, a dedicated private banker will help build your financial plan, investment mandate & undertake a comprehensive portfolio review for free.

IME Capital Logo

IME Capital is a research-first investments firm. We aim to disrupt the wealth management industry, by shrinking the gap in investment insights between central research teams & RMs/Clients.

Disclaimer MF/PMS/AIF/Direct Equities are all subject to market risks. Please read the scheme information and other related documents carefully prior to investing. Past performance is not indicative of future returns. Please consider your specific investment requirements before choosing a fund or designing a portfolio that suits your needs. Market & other data on this site has been sourced from what are considered to be reliable sources. All views shared (product ratings, views on individual securities etc.) are the proprietary property of IME Capital and cannot be used in any form without explicit written consent. IME Capital Pvt. Ltd. makes no warranties or representations, express or implied, on products offered through the platform (and that of our partners) or on the correctness of data & views shared. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Detailed Disclaimer | © 2021 All rights reserved | ARN No: ARN-182445